List of insiders holdings for Traws Pharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
TPAV LLC 10% Owner | 2024-04-11 17:41:38 | 37,775,701 0 | 37,775,701 | Form 3/A |
ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 2020-01-10 16:03:34 | 7,286,201 0 | 7,286,201 | Form 13G |
Michael & Jane Hoffman 2013 Descendants 10% Owner | 2014-02-24 07:51:19 | 4,518,275 0 | 4,518,275 | Form 4 |
Viriom Inc. 10% Owner | 2024-04-08 21:37:11 | 2,934,525 0 | 2,934,525 | Form 13D |
Baxter Healthcare SA 10% Owner | 2015-05-08 18:50:05 | 2,603,295 0 | 2,603,295 | Form 4 |
Baxter Healthcare SA BAXTER INTERNATIONAL INC 10% Owner | 2015-05-08 18:32:29 | 2,603,295 0 | 2,603,295 | Form 13G |
Kumar Ramesh Chief Executive Officer | 2018-07-30 17:25:27 | 1,065,600 0 | 1,065,600 | Form 4 |
Pauza Charles David Chief Science Officer Virology | 2024-04-03 20:04:16 | 933,863 0 | 933,863 | Form 4 |
ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC 10% Owner | 2024-09-23 18:44:56 | 602,000 0 | 602,000 | Form 13D |
Maniar Manoj SVP - Product Development | 2020-07-10 17:43:55 | 418,600 0 | 418,600 | Form 4 |
Woodman Richard Charles Chief Medical Officer | 2020-07-10 17:46:15 | 396,000 0 | 396,000 | Form 4 |
Baxalta GmbH Baxalta Inc 10% Owner | 2017-02-06 14:02:59 | 260,329 0 | 260,329 | Form 13G |
CAUTREELS WERNER Chief Executive Officer | 2024-04-03 20:03:08 | 200,000 0 | 200,000 | Form 4 |
Greenwood Luba Director | 2024-09-17 17:12:11 | 164,000 0 | 164,000 | Form 4 |
Savchuk Nikolay Chief Operating Officer | 2024-08-07 15:46:24 | 134,187 0 | 134,187 | Form 4/A |
Dukes Iain D. Executive Chairman | 2024-08-07 15:47:52 | 134,187 0 | 134,187 | Form 4/A |
Moyo Victor M CHIEF MEDICAL OFFICER | 2023-10-27 16:41:11 | 125,000 0 | 125,000 | Form 4 |
Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | 2024-03-15 17:36:28 | 121,014 0 | 121,014 | Form 4 |
683 Capital Management LLC 683 Capital Partners LP Zweiman Ari Former 10% Owner | 2020-02-18 18:59:37 | 100,000 0 | 100,000 | Form 13D |
Redfield Robert Acting Chief Medical Officer | 2024-04-03 20:07:09 | 97,500 0 | 97,500 | Form 4 |
Gelder Mark S. MD CHIEF MEDICAL OFFICER | 2023-03-14 18:46:02 | 82,667 0 | 82,667 | Form 4 |
OLER ABRAHAM N. SVP Corp Dev & Gen Counsel | 2022-02-09 16:38:57 | 71,683 0 | 71,683 | Form 4 |
MCKEARN THOMAS J President, R&D | 2016-01-28 17:42:53 | 71,029 0 | 71,029 | Form 4 |
BANSAL AJAY Chief Financial Officer | 2016-01-28 17:45:41 | 69,984 0 | 69,984 | Form 4 |
MARINO JAMES J Director | 2023-08-14 17:41:42 | 66,468 0 | 66,468 | Form 4 |
Shoemaker Mary Teresa Director | 2023-08-14 17:53:50 | 66,468 0 | 66,468 | Form 4 |
STOVER JACK E Director | 2023-08-14 17:52:24 | 66,468 0 | 66,468 | Form 4 |
Atadja Peter Director | 2023-08-14 17:49:59 | 66,468 0 | 66,468 | Form 4 |
Clarke Trafford Director | 2023-08-14 17:47:57 | 66,468 0 | 66,468 | Form 4 |
MEHTA VIREN Director | 2023-08-14 17:45:06 | 66,468 0 | 66,468 | Form 4 |
GROOPMAN JEROME Director | 2023-08-14 17:43:26 | 66,468 0 | 66,468 | Form 4 |
Guerin Mark Patrick CFO | 2024-06-20 16:25:24 | 44,755 0 | 44,755 | Form 4 |
TYNDALL CAPITAL PARTNERS L P 10% Owner | 2020-02-14 16:29:39 | 26,042 0 | 26,042 | Form 13G |
Bienen Henry S Director | 2018-05-31 17:27:56 | 22,724 0 | 22,724 | Form 4 |
Hoffman Michael B Director | 2020-08-31 16:42:48 | 0 22,483 | 22,483 | Form 4 |
Reddy E Premkumar Director | 2020-08-31 16:49:39 | 16,683 0 | 16,683 | Form 4 |
Altland James SVP, Finance & Corp. Develop. | 2013-12-24 14:22:43 | 12,000 0 | 12,000 | Form 4 |
VANLENT ANNE Director | 2015-06-17 10:17:45 | 10,000 0 | 10,000 | Form 4 |